Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- HSIIndependent statistical analysis of Home Safety Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06216327).
- HSPvsHSPASIIndependent statistical analysis of Hot Snare Versus Hot Snare Polypectomy With Saline Injection for Colorectal Polyps: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HSV1/HCVIndependent statistical analysis of Herpes Simplex Type 1 Suppression in Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01580995).
- HULKIndependent statistical analysis of Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HUM21469Independent statistical analysis of Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Membrane to Decrease Post Operative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04130061).
- Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: Complete Statistical AnalysisIndependent statistical analysis of Human Amniotic Tissue-derived Allograft, NuCel, in Posteriolateral Lumbar Fusions for Degenerative Disc Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Human Factor Validation of Pediatric Mobility Device: Complete Statistical AnalysisIndependent statistical analysis of Human Factor Validation of Pediatric Mobility Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03714256).
- Human Lung Responses to Respiratory Pathogens: Complete Statistical AnalysisIndependent statistical analysis of Human Lung Responses to Respiratory Pathogens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01967628).
- Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection: Complete Statistical AnalysisIndependent statistical analysis of Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00513526).
- Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema: Complete Statistical AnalysisIndependent statistical analysis of Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HUMBOLDTIndependent statistical analysis of Study to Evaluate the Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HUPKIndependent statistical analysis of Pharmacokinetics of Oral Hydroxyurea Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03763656).
- HVTN 120Independent statistical analysis of Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants: primary endpoint results, effect estimate with confidence interval,…
- HVTN 135Independent statistical analysis of Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants: primary endpoint results, effect estimate with confidence interval, sample-size…
- HVTN119Independent statistical analysis of Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA: primary endpoint results, effect estimate with confidence interval, sample-size…
- HVTN702Independent statistical analysis of Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- HW005Independent statistical analysis of Clinical Evaluation of HW005 Ventricular Assist System for the Treatment of Advanced Heart Failure in Japan: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Hyaluronidase Effect on Infusion Set Life: Complete Statistical AnalysisIndependent statistical analysis of Hyaluronidase Effect on Infusion Set Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02199028).
- HybridIndependent statistical analysis of A Comparison of Stryker Hybrid Arch Bars: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02283528).
- Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: Complete Statistical AnalysisIndependent statistical analysis of Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01609842).
- Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00902538).
- Hydroxychloroquine and Cognitive Function After Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Cognitive Function After Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03025087).
- Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01573754).
- Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04372017).
- Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03275870).
- Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19): Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04318444).
- Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hyp-hOPIndependent statistical analysis of Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- HYPERIONIndependent statistical analysis of Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- HyperlinkIndependent statistical analysis of Home Blood Pressure Telemonitoring and Case Management to Control Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00781365).
- Hyperthermic Yoga for Depressive Symptoms: Complete Statistical AnalysisIndependent statistical analysis of Hyperthermic Yoga for Depressive Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02607514).
- Hypertonic Resuscitation Following Traumatic Injury: Complete Statistical AnalysisIndependent statistical analysis of Hypertonic Resuscitation Following Traumatic Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00316017).
- Hypertonic Saline for Acute Bronchiolitis: Complete Statistical AnalysisIndependent statistical analysis of Hypertonic Saline for Acute Bronchiolitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01247064).
- Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: Complete Statistical AnalysisIndependent statistical analysis of Hypnotherapy With Audiofiles for Children and Adolescents With Disorders of Gut-brain Interactions in Sweden -a Feasibility Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- HypoANSIndependent statistical analysis of Hypoglycemia and Autonomic Nervous System Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01816893).
- Hypofractionated IMRT With Temozolomide for HGG: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated IMRT With Temozolomide for HGG: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02082119).
- Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery: Complete Statistical AnalysisIndependent statistical analysis of Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- HypoResusIndependent statistical analysis of Field Trial of Hypotensive Versus Standard Resuscitation for Hemorrhagic Shock After Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR): Complete Statistical AnalysisIndependent statistical analysis of Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- HYROSIndependent statistical analysis of HYbrid RObotic Surgery in Urology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05864040).
- Hysteroscopic Lymphatic Mapping for Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Hysteroscopic Lymphatic Mapping for Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00671606).
- I-D-HEALTHIndependent statistical analysis of Intervening in Diabetes With Healthy Eating, Activity, and Linkages To Healthcare - The I-D-HEALTH Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- I-KANIndependent statistical analysis of The I-KAN Study: Internet Insulin Education for Kansans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01408628).
- i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management: Complete Statistical AnalysisIndependent statistical analysis of i-Matter: Investigating an mHealth Texting Tool for Embedding Patient-reported Data Into Diabetes Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- I-SCREENIndependent statistical analysis of Increasing Screening for Cancer Using EHR-Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06177795).
- I2PETHVIndependent statistical analysis of I2PETHV - Imidazoline2 Binding Site in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02323217).
- IASISIndependent statistical analysis of Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative Pneumonia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…